Revvity | PKI - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
Agilent USD 282.22M 478K 2026-03
Align Technology USD 71.62M 133K 2026-03
Bio Techne USD 156.45M 703K 2026-03
Bio-Rad Laboratories USD 26.99M 18K 2025-12
Bruker USD 152.22M 282K 2026-03
Celltrion KRW 218.61M 162.21K 2025-12
Charles River Laboratories USD 48.17M 1.05M 2026-03
Cspc Pharmaceutical CNY 11.52B 3.7M 2025-12
Danaher USD 707.7M 800K 2026-03
Dentsply International USD 200.3M 700K 2026-03
Deva Holding AS TRY 200.02M 0 2023-09
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Divis Laboratories Ltd INR 265.47M 0 2026-03
Edwards Lifesciences USD 580.7M 0 2025-12
Illumina USD 151.91M 893K 2026-03
Intuitive Surgical USD 355.17M 674K 2026-03
IQVIA Holdings USD 166.9M 2.7M 2026-03
Kangmei Pharma CNY 13.83B 0 2026-03
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Laboratorios Farma EUR 51.82M 1.55M 2023-12
Laboratory Of America USD 82.3M 100K 2026-03
Malin Corporation EUR 200K 0 2024-12
Medical Developments International AUD 112.66M 2.35M 2025-12
Mesa Laboratories USD 349.53M 3.53M 2024-09
Mettler Toledo International USD 20.25M 179.94K 2026-03
Myriad Genetics USD 93.5M 400K 2025-12
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Organigram Holdings CAD 135.13M 671.75K 2025-12
Ovoca Bio EUR 29.49M 18.43M 2025-06
Pacific Biosciences Of California USD 301.96M 103K 2025-12
Pharma Mar EUR 17.36M 0 2026-03
Qiagen NV USD 216.56M 284.67K 2025-12
Quest Diagnostics USD 111M 1000K 2026-03
Quidel USD 67.9M 0 2025-12
Repligen USD 56.4M 74K 2026-03
Revvity USD 111.8M 1.57M 2026-03
Sartorius EUR 69.05M 0 2026-03
Sino Biopharmaceutical CNY 17.89B 30.5M 2025-06
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
Tilray USD 116.52M 5.01M 2025-09
Waters USD 98.17M 89K 2026-03
Zealand Pharma A/S 70.61M 319.68K 2025-12
Zz Pientze Pharmaceu CNY 603.32M 0 2026-03